Teachers Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.2M Buy
149,353
+6,879
+5% +$37.2K ﹤0.01% 2211
2018
Q4
$584K Buy
142,474
+15,069
+12% +$74.9K ﹤0.01% 2442
2018
Q3
$713K Buy
127,405
+5,221
+4% +$59.7K ﹤0.01% 2484
2018
Q2
$1.61M Buy
122,184
+10,225
+9% +$141K ﹤0.01% 2087
2018
Q1
$1.59M Buy
111,959
+23,223
+26% +$297K ﹤0.01% 1969
2017
Q4
$728K Hold
88,736
﹤0.01% 2390
2017
Q3
$1.05M Hold
88,736
﹤0.01% 2205
2017
Q2
$892K Buy
88,736
+13,304
+18% +$149K ﹤0.01% 2299
2017
Q1
$879K Buy
75,432
+5,000
+7% +$35.9K ﹤0.01% 2260
2016
Q4
$328K Buy
70,432
+13,887
+25% +$81.4K ﹤0.01% 2736
2016
Q3
$438K Hold
56,545
﹤0.01% 2538
2016
Q2
$343K Buy
56,545
+2,961
+6% +$24.1K ﹤0.01% 2620
2016
Q1
$457K Hold
53,584
﹤0.01% 2393
2015
Q4
$639K Buy
53,584
+1,902
+4% +$24K ﹤0.01% 2263
2015
Q3
$521K Hold
51,682
﹤0.01% 2370
2015
Q2
$857K Buy
51,682
+13,117
+34% +$208K ﹤0.01% 2209
2015
Q1
$597K Buy
38,565
+5,637
+17% +$85.3K ﹤0.01% 2330
2014
Q4
$522K Hold
32,928
﹤0.01% 2420
2014
Q3
$351K Hold
32,928
﹤0.01% 2593
2014
Q2
$309K Buy
32,928
+11,683
+55% +$74.7K ﹤0.01% 2721
2014
Q1
$147K Hold
21,245
﹤0.01% 2966
2013
Q4
$83K Hold
21,245
﹤0.01% 3042
2013
Q3
$108K Buy
21,245
+4,021
+23% +$24.6K ﹤0.01% 2993
2013
Q2
$110K Buy
+17,224
New +$110K ﹤0.01% 2976

Other funds holding TGTX

Teachers Advisors's TGTX Position: Q1 2019 in Review

Teachers Advisors increased its TG Therapeutics (TGTX) stake by 4.8% in Q1 2019, buying an estimated $37.2K and bringing the position to 149,353 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Teachers Advisors first reported a position in TGTX in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.61M in Q2 2018. 113 funds tracked by Wall St. Rank hold TGTX as of Q1 2019.

  • Teachers Advisors held 149,353 shares of TG Therapeutics worth $1.2M as of Q1 2019.
  • Teachers Advisors bought 6,879 TG Therapeutics shares in Q1 2019, an estimated $37.2K.
  • TG Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2211 holding.
  • Teachers Advisors first reported a position in TG Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's TG Therapeutics position peaked at $1.61M in Q2 2018.
  • 113 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.